235.80DKK-0.84%Mkt Cap: 49.73B DKKP/E: 21.05Last update: 2026-05-13
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hea…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)21.05
P/E (Forward)15.79
PEG0.77
P/B5.05
P/S2.16
EV/EBITDA14.82
EV/Revenue3.02
EPS (TTM)11.20
EPS (Forward)14.93
Cash Flow & Leverage
FCF Yield6.59%
FCF Margin14.28%
Operating CF3.85B DKK
CapEx (TTM)857.00M DKK
Net Debt/EBITDA4.20
Net Debt19.66B DKK
Technical
SMA 50203.16 (+16.1%)
SMA 200217.61 (+8.4%)
Beta0.71
S&P 52W Chg24.23%
Avg Vol (30d)474.89K
Avg Vol (10d)553.25K
Technical Indicators
RSI (14)65.4
MACD9.7446
MACD Signal7.2200
MACD Hist.+2.5246
BB Upper245.34 DKK
BB Middle217.31 DKK
BB Lower189.28 DKK
BB Width25.80%
ATR (14)8.346 DKK
Vol Ratio (20d)1.00x
52W Range
175.0052% of range293.00
52W High293.00 DKK
52W Low175.00 DKK
Profitability
Gross Margin75.62%
EBITDA Margin20.40%
Profit Margin6.73%
Oper. Margin18.05%
ROE15.70%
ROA3.95%
Revenue Growth3.40%
Earnings Growth-63.40%
Balance Sheet
Debt/Equity2.13
Current Ratio1.36
Quick Ratio0.81
Book Value/Sh46.67 DKK
Cash/Share6.306 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 26, 2000
Pay Date—
Splits
Last Split5:1
Split DateMay 25, 2016
Ownership
Shares Out.210.90M
Float83.77M
Insiders58.90%
Institutions17.02%
Analyst Consensus
Rating1.9 (Buy)
Target (Mean)237.79 DKK
Target Range170.00 DKK – 275.00 DKK
# Analysts19
Company
Market Cap49.73B DKK
Enterprise Value69.46B DKK
Revenue (TTM)22.97B DKK
Gross Profit17.37B DKK
Net Income (TTM)1.54B DKK
Revenue/Share108.71 DKK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees23.4K
Last Price235.80 DKK
CountryDK
SectorHealthcare
IndustryMedical Devices
ISIN—